Navigation Links
Eastern Clinical Trials Russia-CEE Joins BIOCOM CRO
Date:5/1/2013

Moscow, Russia (PRWEB) May 01, 2013

Eastern Clinical Trials (ECT), a contract research organization (CRO) with operations in Russia, Central and Eastern Europe, is pleased to announce that ECT has joined BIOCOM CRO. BIOCOM CRO is a newly created Initiative by BIOCOM (San Diego) the largest regional life science association in the world.     "We are proud to become a member of BIOCOM CRO, a network consisting of the most reputable Life Science Companies and CROs in the Southern California region", said Dr. Svetlana Vodolazhskaya, ECT's Managing Director. "We look forward to being actively involved in the strategy and direction of the rapidly expanding Clinical Research outsourcing community in connecting clinical research programs on a global basis".

Representing Eastern Clinical Trials on BIOCOM CRO advisory committee is Jack Florio, ECT’s representative in the San Diego office. Jack can be reached at jack(dot)florio(at)easterntrials(dot)com
or +1 (858) 864-4339.

About Eastern Clinical Trials (ECT http://www.easterntrials.com)
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

About BIOCOM CRO (http://www.biocomcro.org )
BIOCOM CRO is an initiative created by BIOCOM, the world’s largest life science association with 550 members in the Southern California region.

ECT Contact:
Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189
svetlana(dot)vodolazhskaya(at)easterntrials(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10681667.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
2. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
3. Eastern Clinical Trials Russia CRO Passes EMA Inspection
4. Aviir Signs Distribution and Expansion Pact Covering 19 Middle Eastern and North African Countries
5. Aviir Signs Distribution And Expansion Pact Covering 19 Middle Eastern And North African Countries
6. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
7. Positive Clinical Study Results for BSPs HyperQ Technology
8. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
9. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
10. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
11. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Food and Drug Administration (FDA) has accepted the ... for DSUVIA™ (formerly ARX-04) (sufentanil sublingual tablet, 30 ... acute pain in a medically supervised setting. The ...
(Date:2/27/2017)... FRANCISCO , Feb. 27, 2017 Fluxion ... Spain has been appointed as a ... System. The IsoFlux system will be used in Genetracer ... relevant to lung and colon cancer, with plans to ... The laboratory is utilizing Fluxion,s IsoFlux System to isolate, ...
(Date:2/26/2017)... ... February 26, 2017 , ... Rob Lowe is a well recognized television personality, ... "Informed," focuses on issues that are important to the American public and important to ... has been a hot topic around the world for a few years. , The ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Delpor, Inc. ... $224K grant from the National Institute of Mental Health (NIMH) for the further advancement ... Delpor’s PROZOR technology and is expected to deliver therapeutic levels of olanzapine ...
Breaking Biology Technology:
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special Counsel to ... of Identity Strategy Partners, LLP, today releases the following ... Protecting the Nation From Foreign Terrorist Entry Into the ... Trump,s ,Travel Ban, Executive Order gains more notoriety and ... ban, it is important that our national discourse regain ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
(Date:2/7/2017)... LONG BEACH, New York , February 7, 2017 ... formerly known as ID Global Solutions Corporation [OTC: IDGS], ... identification, identity management and electronic transaction processing services, is ... a reorganization of the Company. Effective January ... Chairman of the Board of Directors, CEO and President. ...
Breaking Biology News(10 mins):